Since the Global Fund’s establishment in 2002, businesses have contributed their assets and expertise to the Global Fund, both through membership in the PSC and through other partnerships and programs. Their contributions range from financial contributions, technical services and advocacy to co-investments and operational support of in-country programs.
During the Global Fund’s Fifth Replenishment Conference in 2016, pledges from private donors and innovative financing initiatives reached US $250 million for the 2017-2019 period, more than twice as much as in the previous period. For more information on the private sector’s contributions to the Fund, please click here.
Chevron – Corporate Champion
Chevron became the first Global Fund Corporate Champion in January 2008 when they announced a US$ 30 million commitment to the Global Fund at the World Economic Forum. Since then, they have increased their eight-year investment (2008-2015) to a total of US$ 60 million. This is the largest contribution from a single corporation to the Global Fund. For more information on Chevron’s role as Corporate Champion, please click here.
In December 2013, Sustainable Communities pledged US$ 10 million to the Global Fund to achieve universal malaria prevention coverage in Mozambique by 2014. The contribution will be made over 2014-2016, and additional interventions will be made every year to support the goal of universal coverage. For more information on BHP Billiton’s contribution and partnership with the Global Fund, please click here.
Takeda made a US$ 10 million commitment to the Global Fund, over the 2010-2019, period to strengthen the capacity of healthcare workers in Africa. Part of the “Takeda Initiative,” these funds will be directed to Global Fund programs for health systems strengthening and human capacity development initiatives. For more information on Takeda’s partnership with the Global Fund, please click here.
Anglo American plc led a Call for Joint Action on Global Health at the 2010 G20 Business Summit in Seoul, South Korea alongside fellow Global Fund donor Takeda Pharmaceuticals. At the Summit, Anglo American pledged a contribution of US$ 3 million to the Global Fund over 3 years. For more information on Anglo American’s Global Fund contribution, please click here.
SAP partnered with USAID and Grant Management Solutions to develop a grant oversight platform to enable Principle Recipients to make better and more informed decisions on grant management and performance. The partnership has provided technical support to grantees of the Global Fund in 61 countries and has supported signature of more than US $2.5 billion worth of grants. For more information on the Grant Management Solutions partnership, please click here.
Marathon Oil led the “Bioko Island Malaria Project” in partnership with the Government of Equatorial Guinea, Noble Energy, GEPetrol and SONAGAS. In 2008, these partners announced a five-year US$ 28 million extension of the project with a US$ 26 million contribution from the Global Fund. As a result of the project, malaria transmission by mosquitoes was down in 2016 by nearly 70 percent amongst children 2 to 14 years old. For more information on the extension of the Bioko Island Malaria Project, please click here.
Comic Relief, a popular U.K. and U.S. charity, and the Global Fund have been partners since 2009. At the Global Fund’s preparatory replenishment meeting in Tokyo in December 2015, Comic Relief announced a three-year partnership through donations raised during its annual events: Red Nose Day and Sport Relief in the U.K. and Red Nose Day in America. Comic Relief has pledged US $12.75 to the Global Fund over the 2017-2019 Replenishment Period. For more information on the partnership between the Global Fund and Comic Relief, please click here.
Gift from Africa
Gift from Africa is a joint financing initiative formed by African businesses to fight the three diseases in Africa. Companies like Access Bank, Anglo American, Cirrus Oil and others launched the campaign in 2010 with initial pledges of US$ 3 million. For more information on ‘Gift from Africa’ please click here.
Product (RED) was created by Bono to generate sustainable funds for life-saving HIV/AIDS treatment in Africa. The campaign has attracted a range of companies from Starbucks to Dell to create (RED) products with proceeds benefiting the Global Fund. As of 2016, (RED) has contributed over US $365 million to support Global Fund HIV/AIDS grants in Ghana, Kenya, Lesotho, Rwanda, South Africa, Swaziland, Tanzania and Zambia. For more information on Product (RED), please click here.
Established in the will of Sir Ratan Tata in 1919, Tata Trust is now one of the oldest grant bestowing foundations in India. In 2016, Tata Trusts and the Global Fund launched the India Health Fund, an innovative initiative to raise funds within India and invest the money to tackle key health challenges, starting with tuberculosis and malaria. For more information on the India Health Fund, please click here.
|Private Sector CCM Members||Country|
|Bralima (subsidiary of Heineken)||Democratic Republic of Congo|
|Brarudi (subsidiary of Heineken)||Burundi|
|De Beers||South Africa|
|Pfizer Philippines Foundation||Philippines|
|Standard Chartered Bank||Malaysia|
AngloGold Ashanti became the first private sector Principal Recipient in Africa with a Global Fund grant of up to US $130 million starting in 2010. Through this additional funding they will expand their successful integrated malaria control program into 40 districts in Ghana, through a public-private partnership model. For more information on AngloGold Ashanti’s malaria control program, please click here.
In 2006 Pilipinas Shell Foundation was the Principal Recipient of the Global Fund’s Round 5 malaria grant in the amount of US$ 14.3 million. By 2010, the Foundation’s work had reduced malaria morbidity by 63.7 percent and mortality by 92.7 percent, compared to 2003 baseline rates in the five provinces most affected by the disease. In January 2010, Pilipinas Shell signed a consolidated malaria grant with the Global Fund in the amount of US$ 31.4 million, with the goal of reducing malaria morbidity and mortality rates nationwide by 70 percent by the end of 2014. For more information on Pilipanas Shell Foundation’s program, please click here.
Oil Search Health Foundation is responsible for the implementation and management of a stage 2 Global Fund malaria grant and a phase 1 Global Fund HIV health systems strengthening grant in Papua New Guinea. Oil Search will administer more than a total of US$ 60 million in the malaria grant that ends in 2014 and the HIV grant ending in early 2017. The company is proud to be one of just three private sector companies to be granted Principal Recipient status by the Global Fund. Oil Search’s malaria program saw incidence decrease from 315 per 1,000 people in 2010 to 120 per 1,000 people in 2011 and its HIV program recorded its 30,000th HIV test in July 2013. For more information on Oil Search Health Foundation programs, please click here.
Accenture Development Partnerships collaborates with over 640 international development organizations to deliver innovative solutions that change the way people work and live, such as the Global Fund’s Last Mile Partnership. Its award-winning business model enables Accenture’s core capabilities– its best people and strategic business, technology and project management expertise–to be made available to the international development sector on a not-for-profit basis.
Ecobank is a leading pan-African financial institution that operates in 35 countries in Africa and embraces the mission of contributing to the economic and financial development of Africa. Ecobank and the Ecobank Foundation joined the Global Fund partnership in 2013, to strengthen the financial management capabilities of grant recipients in Nigeria, Senegal and South Sudan. The initial contribution of US $3 million over three years included US $1.5 million in cash and in-kind services and training. For more information on this project, please click here.
Novartis and Sanofi, leading manufacturers of artemisinin-based combination therapies (ACTs), the most effective malaria treatment, provide their medicines to governments, NGOs and international organizations on a “no profit, no loss” basis as part of each company’s commitment to combating malaria and increasing access to medicines. Since 2010, both companies have been supplying ACTs on a not-for-profit basis to the Affordable Medicines Facility – malaria (AMFm) initiative, which is managed by the Global Fund.
For more information on the Affordable Medicines Facility – malaria (AMFm), please click here.
The Coca-Cola Company is working with the Tanzanian Ministry of Health’s Medical Stores Department (MSD) to assist with their supply chain management and ensure essential medicines are made available in a time/cost-effective manner. Tanzania has the second largest Global Fund grant in sub-Saharan Africa. Early outcomes from the pilot project have shown a 25% cost savings on the distribution network, and the model is also being expanded to Ghana and Mozambique.
For more information on this project, please click here.
Standard Bank has been the Global Fund’s partner since 2008. Through this collaboration, Standard Bank is providing financial and management expertise to recipients of Global Fund grants in selected African countries to help ensure that funds are efficiently managed, spent and distributed inside the country and to assist with reporting requirements. Standard Bank’s support is available to grant recipients in selected countries who request it and is tailored to meet their specific needs.